High Tech (Korea) Performance

106190 Stock  KRW 16,090  590.00  3.81%   
On a scale of 0 to 100, High Tech holds a performance score of 11. The company retains a Market Volatility (i.e., Beta) of -0.3, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning High Tech are expected to decrease at a much lower rate. During the bear market, High Tech is likely to outperform the market. Please check High Tech's market risk adjusted performance, semi deviation, coefficient of variation, as well as the relationship between the mean deviation and downside deviation , to make a quick decision on whether High Tech's current trending patterns will revert.

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in High Tech Pharm are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, High Tech sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Total Cashflows From Investing Activities-1.3 B
  

High Tech Relative Risk vs. Return Landscape

If you would invest  1,333,619  in High Tech Pharm on December 20, 2024 and sell it today you would earn a total of  275,381  from holding High Tech Pharm or generate 20.65% return on investment over 90 days. High Tech Pharm is generating 0.3674% of daily returns and assumes 2.5288% volatility on return distribution over the 90 days horizon. Simply put, 22% of stocks are less volatile than High, and 93% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon High Tech is expected to generate 2.97 times more return on investment than the market. However, the company is 2.97 times more volatile than its market benchmark. It trades about 0.15 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.04 per unit of risk.

High Tech Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for High Tech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as High Tech Pharm, and traders can use it to determine the average amount a High Tech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1453

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns106190
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 2.53
  actual daily
22
78% of assets are more volatile

Expected Return

 0.37
  actual daily
7
93% of assets have higher returns

Risk-Adjusted Return

 0.15
  actual daily
11
89% of assets perform better
Based on monthly moving average High Tech is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of High Tech by adding it to a well-diversified portfolio.

High Tech Fundamentals Growth

High Stock prices reflect investors' perceptions of the future prospects and financial health of High Tech, and High Tech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on High Stock performance.

About High Tech Performance

By analyzing High Tech's fundamental ratios, stakeholders can gain valuable insights into High Tech's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if High Tech has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if High Tech has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
High Tech Pharm Co., Ltd. develops, manufactures, sells, and distributes antibiotic pharmaceutical ingredients for injections for hospitals and doctors.

Things to note about High Tech Pharm performance evaluation

Checking the ongoing alerts about High Tech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for High Tech Pharm help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
The company reported the revenue of 73.29 B. Net Loss for the year was (1.23 B) with profit before overhead, payroll, taxes, and interest of 1.31 B.
About 45.0% of the company shares are owned by insiders or employees
Evaluating High Tech's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate High Tech's stock performance include:
  • Analyzing High Tech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether High Tech's stock is overvalued or undervalued compared to its peers.
  • Examining High Tech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating High Tech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of High Tech's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of High Tech's stock. These opinions can provide insight into High Tech's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating High Tech's stock performance is not an exact science, and many factors can impact High Tech's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for High Stock analysis

When running High Tech's price analysis, check to measure High Tech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy High Tech is operating at the current time. Most of High Tech's value examination focuses on studying past and present price action to predict the probability of High Tech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move High Tech's price. Additionally, you may evaluate how the addition of High Tech to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
CEOs Directory
Screen CEOs from public companies around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal